Fig. 2From: Development of [225Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibrationCell binding of [225Ac]Ac-DOTA-C595 at 1 × 105 cells corrected for background. r2 values of 0.9425, 0.9576, 0.9892 and 0.9658 respectively for PANC-1, CAPAN-1, BxPC-3 and AsPC-1 cell linesBack to article page